Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing.

In a fundraise, one typically uses the same term sheet throughout the raise.

From time to time, investors will demand certain rights and conditions.  

If there are no investor representations, then you may be able to do so.

For some investors, you may need to vary the terms of the raise and use a different term sheet.

The key is to keep the valuation the same but add additional terms to make the deal more attractive.

Additional terms include most-favored-nation status which means the investor gets the best deal that anyone else in the round gets. 

It also could include advisory and board positions, warrants, or redemption rights.

Lead investors often ask for special terms to compensate for their time and effort.

Investors spending time mentoring the team also may ask for these considerations.

Before changing the terms or using new term sheets, you should check with your attorney.


Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding.

Let’s go startup something today.
___________________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org 

Check out our other podcasts here: https://investorconnect.org/ 
For Investors check out: https://tencapital.group/investor-landing/ 
For Startups check out: https://tencapital.group/company-landing/ 
For eGuides check out: https://tencapital.group/education/ 
For upcoming Events, check out https://tencapital.group/events/ 

For Feedback please contact info@tencapital.group 

Music courtesy of Bensound.

In this episode, Hall welcomes Dr. Stuart Titus, Chief Executive Officer and President at Medical Marijuana, Inc.

Headquartered in Poway, California, Medical Marijuana, Inc. is a cannabis product research and development company. The Company offers various CBD oils and related products such as CBD tinctures, concentrates, beauty products and pet supplements. Medical Marijuana distributes its products to worldwide customers.

Stuart, a 10+ year pioneer of the cannabis industry, is the CEO of the first-ever publicly traded cannabis company in the US, Medical Marijuana, Inc. He has been involved in all aspects of the medical marijuana and industrial hemp industries overseeing a robust portfolio of subsidiaries and investments. Through his leadership, Medical Marijuana, Inc. became the first company to deliver cannabis brands across U.S. state lines, and the first to hold import permits for hemp-derived cannabidiol (CBD) in dozens of countries such as Mexico, Brazil, Paraguay, Argentina and many European nations.  

He is also a veteran of the financial services and medical healthcare industries with over thirty years of combined experience in each discipline. In the investment banking industry, Stuart worked with well-regarded firms including A.G. Becker, Prudential-Bache Securities, and Credit Suisse-First Boston.

Stuart shares with Hall how he sees the industry evolving and some of the challenges startups face.

You can visit Medical Marijuana, Inc. at www.mjnagroup.com, via LinkedIn at www.linkedin.com/company/medical-marijuana-inc-/, and via Twitter at
www.twitter.com/mjna_inc.   

Stuart can be contacted via email at Stuart@mjnagroup.com.

Music courtesy of Bensound.